NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme involved in normal cellular processes, including energy metabolism. The fact that our bodies use it is well established; the effects of adding it as a commercial treatment need their own evidence.
“NAD+ therapy” is a broad label. It may refer to an IV infusion in a clinic, a prescribed injection used at home, a nasal preparation, or sometimes products that contain related substances. Before comparing prices or benefits, find out which ingredient and route a provider actually means.
Identify the ingredient and route first. Then evaluate evidence, clinical fit, pharmacy details, and total cost.
The molecule and the treatment are different questions
Learning that a substance is important in the body does not tell us that taking more improves health. A treatment claim needs evidence about the preparation, amount, route, people studied, and outcome measured. That is why a scientific explanation of cellular metabolism is a starting point, rather than proof of a commercial promise.
The NIH niacin fact sheet provides useful nutritional background. It should not be read as an endorsement of an injectable NAD+ program. Our evidence guide takes the next step and explains what the human research can support.
Know the route before choosing a provider
An IV infusion enters a vein and requires an appropriate clinical setting and supervision. A home injection has its own prescription, equipment, training, and storage requirements. A nasal product uses another route and device. Oral NR and NMN are precursors, not simply the same injection in capsule form.
Ask the provider to name the exact ingredient on the proposed prescription. Then read our injection, IV, and nasal comparison. Practical convenience and clinical effectiveness are separate considerations; a shorter appointment or a needle-free option does not prove better health outcomes.
What compounded means here
A compounded medicine is prepared for a clinical need through a pharmacy process. It is not an FDA-approved finished drug. An advertisement mentioning an FDA-registered facility does not change that distinction.
Obtain the pharmacy’s name and contact information, and ask why the proposed compounded preparation fits your situation. For injectable products, ingredient suitability and contamination control are particularly relevant. Our compounding guide discusses the FDA notice and the questions to ask without pretending a review site can inspect your vial.
A useful first conversation
Describe the problem you want help with in ordinary terms: what changed, when it started, and how it affects your day. Bring your medication and supplement list. Ask whether another evaluation should come before a decision about NAD+.
Discuss your preference for in-person or remote care, your comfort with the proposed route, and your budget for the full course being considered. Ask what follow-up would look like and what would count as a reason to stop. You can use our appointment checklist as a printable prompt.
Where to go next
If you want a nearby conversation, start with the state and city directory. Each local guide gives nearby search areas and provider-verification resources; the existence of a city page does not establish that a clinic has availability there.
If you are exploring remote care, compare the provider reviews and their actual billing models. CoreAge Rx, for example, has different prices on two public pages, while Hone separates medication from membership. A clear understanding of the service is a better starting point than a broad anti-aging promise.
Follow the question that brought you here.
For the chemistry, compare NAD+ and NADH, the molecule and pathways, or why NAD is not a peptide. If the letters appeared in a medical report, start with the abbreviation guide. For a shopping question, read oral supplements and NR versus NMN. También puede leer qué es el NAD en español.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- NIH Office of Dietary Supplements: niacin Nutritional and biochemical context; not a clinical trial of NAD+ injections.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- Grant et al. (2019): NAD+ infusion metabolome pilot Small human IV study; metabolic observations do not prove longevity or everyday benefits.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.